CELLINK entered a collaboration with UPM Biomedicals in March which is now running according to plan. The partnership brings together UPM:s expertise for producing non-animal derived, nanocellulose biomaterials with CELLINK’s years of experience in method development for 3D bioprinting, offering new ground-breaking solutions to this growing life sciences market.
CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments
